Skip to main content
All lobbying filings

STUMPTOWN STRATEGIES

Lobbying for ELANCO ANIMAL HEALTH · Animal Health Drug Manufacturers

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • BLAIR LARKINS
    Previously held: Rep. Greg Walden, Executive Assistant, 2005-2011

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5
Trade (domestic/foreign)

Topics regarding tariff and non-tariff policies impacting the US animal health industry.

Animals

Issues related to emerging animal diseases and measures to prevent and control such diseases Issues related to the regulation of animal medicines and biologicals as well as support for accelerating innovative medicines and biologics for for veterinarians, farmers, and animal owners Issues related to supporting continued access and/or increasing access to medicines for animals.

Environment/Superfund

Discussions related to PRIA

Budget/Appropriations

FY27 animal health priorities

Agriculture

HR 2203/S.1906 - Innovative FEED Act of 2025 Farm Bill - Various titles to support animal health-related topics

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem